Escape From Oncogene-Induced Senescence is Controlled by POU2F2 and Memorized by Chromatin Scars
Ricardo Iván Martínez‐ZamudioiD, Alketa Stefa, José Américo Nabuco Leva Ferreira de FreitasiD, Themistoklis VasilopoulosiD, Mark Simpson, Grégory R G Doré, Pierre‐François RouxiD, Mark A. GalaniD, Ravi J. ChokshiiD, Oliver BischofiD, Utz HerbigiD
Abstract
Although oncogene-induced senescence (OIS) is a potent tumor-suppressor mechanism, recent studies revealed that cells can escape from OIS with features of transformed cells. However, the mechanisms that promote OIS escape remain unclear, and evidence of post-senescent cells in human cancers is missing. Here, we unravel the regulatory mechanisms underlying OIS escape using dynamic multidimensional profiling. We demonstrate a critical role for AP1 and POU2F2 transcription factors for escape from OIS and identify senescence-associated chromatin scars (SACS) as an epigenetic memory of OIS, detectable during colorectal cancer progression. POU2F2 levels are elevated already in precancerous lesions and as cells escape from OIS, and its expression and binding activity to cis-regulatory elements are associated with decreased patient survival. Our results support a model in which POU2F2 exploits a precoded enhancer landscape to promote senescence escape and reveal POU2F2 gene signatures and SACS as valuable biomarkers with diagnostic and prognostic potential.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 44
- FWCI
- 7.81
- Field percentile
- top 2%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Genomic instability is an early event driving chromatin reorganization and escape from oncogene-induced senescence
C. Zampetidis, P. Galanos, … V. G. Gorgoulis·bioRxiv·Dec 20, 2020
- Oncogene inactivation-induced senescence facilitates tumor relapse
Philipp Schmitt, Katrin Hönig, … Thomas Blankenstein·Nature CommunicationsPeer-reviewed·Jul 15, 2026
- Suppression of p16 alleviates the senescence-associated secretory phenotype
R. Buj, K. E. Leon, K. M. Aird·bioRxiv·Aug 19, 2020
- Failed reprogramming of transformed cells due to induction of apoptosis and senescence impairs tumor progression in lung cancer
P. Pedrosa, Z. Zang, … M. Collado·bioRxiv·Oct 19, 2023
- A senescence-like state is beneficial for ovarian cancer treatment
M. Skulimowski, L. Calvo Gonzalez, … F. Rodier·bioRxiv·Sep 30, 2023
- Coordinated post-transcriptional control of oncogene-induced senescence by UNR/CSDE1
Rosario Avolio, Marta Inglés‐Ferrándiz, … Fátima Gebauer·Cell ReportsPeer-reviewed·Jan 1, 2022